ÂÜÀòÂÒÂ×

Verismo Therapeutics

0 followers
‌

Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.

Employees

11-50

Links


Org chart

Bryan Kim
CEO / Co-founder
Collapse
Pavel Aprelev
Director Of Corporate Development / Start-up Member
Raymond Luke
Senior Director of MSAT, Head of CMC
Andrea Campanile
Vice President, Clinical Operations
Richard Sherry
Executive VP of Medical Devlopment
Dennis Williams
Vice President, Global Regulatory Affairs
Ronnie Yuerong Wen
Sr. Director of Finance and Accounting

Board & advisors

Donald Siegel
Co-Founder & Co-Chair, Scientific Advisory Board
Steven M. Albelda
Scientific Advisor
Carl June
Founding Advisor